Presidential Greeting - American Society for Laser Medicine and ...
Presidential Greeting - American Society for Laser Medicine and ...
Presidential Greeting - American Society for Laser Medicine and ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
18 <strong>American</strong> <strong>Society</strong> <strong>for</strong> <strong>Laser</strong> <strong>Medicine</strong> <strong>and</strong> Surgery Abstracts<br />
#58<br />
Study: Patients with at least one hypertrophic active scars or<br />
cheloid, phototypes I to IV, were enrolled in this prospective study.<br />
The scar was treated with a (Ekkylite, Ekkyo, Aix en Provence,<br />
France) 810 nm diode laser system delivering a top hat spot of<br />
20 mm 4 mm. Treatments were applied every 3 weeks. Clinical<br />
evaluations, digital pictures, improvement of life quality, patient’s<br />
satisfaction were per<strong>for</strong>med at each visit, then at 90 <strong>and</strong> 180 days<br />
after the last session.<br />
Results: Fifteen patients, on decoletage, limbs, back, face,<br />
phototypes I to IV were included. Diminution of itching <strong>and</strong><br />
redness, reduced height <strong>and</strong> thickness, <strong>and</strong> whitening were noted<br />
mostly after three sessions on hypertrophic scars. Results were<br />
less reproducible on cheloids.<br />
Conclusion: This innovative 810 nm diode laser is a new device<br />
already used in practice <strong>for</strong> aesthetic surgery, <strong>and</strong> it may be<br />
utilized to improve hypertrophic scar <strong>and</strong> cheloid after surgery.<br />
#57<br />
TREATMENT OF SCARS USING LASER AND<br />
LASER ASSISTED CORTICOSTEROID DELIVERY<br />
Jill Waibel, Stephen Davis, Emmy Graber,<br />
Nathan Uebelhoer<br />
Miami Dermatology <strong>and</strong> <strong>Laser</strong> Institute: University of Miami<br />
Miller School of <strong>Medicine</strong>, Miami, FL; Boston University School of<br />
<strong>Medicine</strong> <strong>and</strong> Boston Medical Center, Boston, MA; Naval Medical<br />
Center San Diego, San Diego, CA<br />
Background: Severe cutaneous scarring affects patients<br />
following trauma, burns <strong>and</strong> surgical procedures. Treating a scar<br />
is a dynamic process since the scar changes as therapy progresses.<br />
A combination of vascular, pigment <strong>and</strong> resurfacing lasers may be<br />
needed <strong>for</strong> maximal scar improvement. Fractional lasers create<br />
zones of ablation at variable depths. These zones may be used<br />
immediately post-operatively to deliver drugs <strong>and</strong> other<br />
substances to synergistically create a therapeutic response. By<br />
delivering topical or intralesional corticosteroids immediately<br />
after fractional laser therapy the drug may take advantage of the<br />
ablative fractional channels to penetrate deep into dermal scars<br />
<strong>and</strong> decrease fibroblast proliferation. Cutaneous scars can be<br />
complex <strong>and</strong> thus the approach to therapy may need to be<br />
multimodal. A new combination therapy is suggested that<br />
incorporates the use of one or more wavelengths of laser in the same<br />
treatment session as topical or intralesional triamcinolone acetonide<br />
to synergistically decrease hypertrophic <strong>and</strong> keloidal scars.<br />
Study: Retrospective study with 15 subjects with hypertrophic or<br />
keloidal scars from 3rd degree burn injury, surgical or traumatic<br />
injuries. Subjects were treated with three to five treatment<br />
sessions of at least one or more wavelengths of laser <strong>and</strong> same day<br />
immediately post-operative topical or intralesional delivery of<br />
triamcinolone acetonide injectable suspension into fractional<br />
ablative tunnels. Three blinded investigators evaluated<br />
photographs taken at baseline <strong>and</strong> 6 months after the final<br />
therapy session. Scores were assigned using a quartile<br />
improvement score to evaluate overall improvement, dyschromia,<br />
degree of hypertrophy <strong>and</strong> texture.<br />
Results: Combination same session laser therapy <strong>and</strong> postoperative<br />
corticosteroid delivery resulted in average overall<br />
improvement of 2.73/3.0. Dyschromia showed the least amount of<br />
improvement with texture showing the most improvement.<br />
Conclusion: Combination same session therapy with multiple<br />
laser wavelengths <strong>and</strong> laser assisted delivery of topical or<br />
intralesional triamcinolone acetonide may offer an efficient, safe<br />
<strong>and</strong> effective treatment of challenging cutaneous scars.<br />
FRACTIONAL ABLATIVE RADIOFREQUENCY<br />
TREATMENT FOR SKIN TYPES V–VI: RISK-<br />
BENEFIT ANALYSIS<br />
Jennifer Chwalek, Mussarrat Hussain,<br />
David Goldberg<br />
Skin <strong>Laser</strong> & Surgery Specialists of NY <strong>and</strong> NJ, New York, NY<br />
Background: <strong>Laser</strong> resurfacing has remained the gold st<strong>and</strong>ard<br />
<strong>for</strong> the treatment of rhytides, dyspigmentation <strong>and</strong> skin laxity <strong>for</strong><br />
many years. However, the potential risks of resurfacing such as<br />
infection, prolonged erythema, pigmentary changes <strong>and</strong> scarring,<br />
especially in darker skin types, have led to a search <strong>for</strong> safer <strong>and</strong><br />
more effective treatments. Radiofrequency (RF) technology<br />
produces volumetric heating of the dermis to elicit collagen<br />
shrinkage <strong>and</strong> skin tightening. Fractionated radiofrequency<br />
devices create controlled radiofrequency thermal zones (RFTZ) at<br />
regularly spaced intervals with intervening normal tissue. Unlike<br />
ablative <strong>and</strong> nonablative laser modalities, which cause significant<br />
epidermal damage, RF devices have minimal epidermal effect <strong>and</strong><br />
may be safer <strong>for</strong> darker skin types. To assess the safety <strong>and</strong><br />
efficacy of a new bipolar ablative radiofrequency device in<br />
the treatment of rhytides <strong>and</strong> texture in patients with skin<br />
types V–VI.<br />
Study: Twenty-five male <strong>and</strong> female subjects 35–70 years of age<br />
with Fitzpatrick skin types V–VI with mild to moderate<br />
photoaging were evaluated. Subjects underwent three monthly<br />
full-face treatments with the fractional ablative radiofrequency<br />
device. Energy settings were increased incrementally at each<br />
treatment session as tolerated. Follow-up evaluations were<br />
per<strong>for</strong>med at each treatment interval <strong>and</strong> at 6 months following<br />
the final treatment. Two non-treating physicians evaluated each<br />
subject <strong>for</strong> changes in rhytides <strong>and</strong> skin texture.<br />
Results: All subjects showed improvement in either rhytides or<br />
skin texture. Post-treatment erythema was seen in 10 subjects.<br />
Post-treatment swelling was seen in only 1 subject after 1<br />
treatment. No pigmentary changes or scars was noted.<br />
Conclusion: Bipolar fractional ablative radiofrequency<br />
treatments may be successfully used to treat photodamage in skin<br />
types V–VI.<br />
#59<br />
THE EFFECTS OF FRACTIONAL<br />
RADIOFREQUENCY MICRONEEDLE ON<br />
PERIORBITAL WRINKLE OF KOREAN PATIENTS<br />
Won-Serk Kim, Ga-young Lee<br />
Kangbuk Samsung Hospital, Sungkyunkwan University School of<br />
<strong>Medicine</strong>, Seoul, Korea<br />
Background: Fractional radiofrequency microneedle (FRM), the<br />
minimally invasive device using insertion microneedles of bipolar<br />
<strong>and</strong> monopolar radiofrequency <strong>for</strong> deep dermal heating, has been<br />
used <strong>for</strong> various cosmetic problems in Korea. Asian periorbital<br />
skin is thicker than white people, so more powerful dermal<br />
heating is necessary. We investigated the usefulness of FRM <strong>for</strong><br />
periorbital wrinkle reduction.<br />
Study: Twenty healthy volunteers with periorbital wrinkle over<br />
grade 2 participated in this study. Every patients had three<br />
treatments with 1-month interval <strong>and</strong> checked clinical<br />
photograph, adverse problems <strong>and</strong> questionnaire about subjective<br />
satisfaction <strong>and</strong> discom<strong>for</strong>ts during 6 months. Pre- <strong>and</strong> postclinical<br />
photographs were used <strong>for</strong> assessing wrinkle severity. It<br />
was assessed by three independent, blinded dermatologists.